• Home>
  • Stocks>
  • Ind-Swift Laboratories Ltd Share Price
Ind-Swift Laboratories Ltd share price logo

Ind-Swift Laboratories Ltd Share Price (INDSWFTLAB)

Check the latest share price of Ind-Swift Laboratories Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹108.571.53%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Ind-Swift Laboratories Ltd Stock Performance

Get live Ind-Swift Laboratories Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹105.81
    Day's Price Range
    ₹109.84
  • 52 Week's Low

    52 Week's High

    ₹68.72
    52-Week Price Range
    ₹186
1 Month Return+ 39.35 %
3 Month Return+ 21.31 %
1 Year Return-8.17 %
3 Year Return+ 86.07 %
5 Year Return+ 258.91 %
Previous Close₹110.26
Open₹107.10
Volume3.36L
Upper Circuit₹132.31
Lower Circuit₹88.20

Ind-Swift Laboratories Ltd Fundamentals & Key Indicators

Check Ind-Swift Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹658.14 Cr

Return on Equity (ROE)

18.99

PE Ratio (TTM)

1.81

Return on capital employed (ROCE)

20.55

Industry PE ratio

57.39

Beta (LTM)

0.64

P/B Ratio

0.63

Dividend Yield

0

PEG Ratio

0.03

Quarterly Earnings Growth YOY

-100.05

EPS (TTM)

71.33

Sector

Pharmaceuticals

Book Value

157.64

Technical Analysis

How to invest in Ind-Swift Laboratories Ltd?

Investing in Ind-Swift Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Ind-Swift Laboratories Ltd or INDSWFTLAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Ind-Swift Laboratories Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Ind-Swift Laboratories Ltd with just a few clicks!

Ind-Swift Laboratories Ltd Stock's Interest Amongst Investors

3.46%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Investment in Ind-Swift Laboratories Ltd Shares on INDmoney has grown by 3.46% over the past 30 days, indicating increased transactional activity.

78%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Ind-Swift Laboratories Ltd Stock has increased by 78% in the last 30 days, reflecting an upward trend in search activity.

Ind-Swift Laboratories Ltd Valuation

Track how Ind-Swift Laboratories Ltd P/E has moved over time to understand its valuation trends.

Ind-Swift Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-1795.00x)

December 8, 2022

Today (1.81x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (64.97x)

July 19, 2021

LowHigh

Today’s Price to Earnings Ratio: 1.81x

Ind-Swift Laboratories Ltd Financial Results

Get the annual and quarterly financial summary of Ind-Swift Laboratories Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25
Revenue

(in ₹ Cr)

288 (0%)393 (37%)33 (92%)12 (64%)9 (28%)
Net Income

(in ₹ Cr)

20 (0%)353 (1706%)1 (100%)0 (60%)-0 (102%)
Net Profit Margin6.79% (0%)89.67% (1221%)3.04% (97%)3.34% (10%)-0.12% (104%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

1817 (0%)1803 (1%)1788 (1%)1105 (38%)
Total Liabilities

(in ₹ Cr)

1178 (0%)1170 (1%)1113 (5%)183 (84%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

123 (0%)135 (10%)136 (1%)183 (34%)-180 (198%)

Ind-Swift Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Ind-Swift Laboratories Ltd.

  • Ind-Swift Laboratories Ltd Earnings Results

    Ind-Swift Laboratories Ltd’s net profit fell -99.95% since last year same period to ₹0.01Cr in the Q3 2024-2025. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -97.56% fall in its net profits since last 3-months.

    Read More about Earnings Results

Ind-Swift Laboratories Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ind-Swift Laboratories Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
40.94%
0.00
Foreign Institutions
3.07%
0.00
Mutual Funds
0%
0.00
Retail Investors
55.07%
0.00
Others
0.91%
0.00

Ind-Swift Laboratories Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA658.1451.78%0.514211,280
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Ind-Swift Laboratories Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Ind-Swift Laboratories Ltd.

  • Ind-Swift Labs Faces Significant Revenue Decline - 28 Apr, 2025

    Ind-Swift Laboratories Ltd experienced a 5.2% drop in stock price, hitting an intraday low of Rs. 76.35. The company reported a nearly 97% year-on-year decline in revenue, from Rs. 287.5 crores to Rs. 8.66 crores, and a 100% decrease in net profit. Additionally, Wilson Holdings offloaded 3 lakh shares in a bulk deal.

Insights on Ind-Swift Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, INDSWFTLAB stock has moved up by 15.1%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.46% to 3.07% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 45.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 53.5%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 56.60% to 55.07% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 352.64 Cr → 0.01 Cr (in ₹), with an average decrease of 84.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 805.18 Cr → 22.48 Cr (in ₹), with an average decrease of 49.4% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 42.00% to 40.94% in Mar 2025 quarter

About Ind-Swift Laboratories Ltd

IndSwift Laboratories Ltd is an Indian based company that manufactures and sell Active Pharmaceutical Ingredients (API). Established in 1995, the company has grown to encompass 25 products, the most significant being Clarithromycin Macrolide antibiotic, Atorvastatin anticholestrol, Fexofenadine antihistamine, Clopidogrel anticholestrol, Nitazoxanide antidiarrheal, Pioglitazone antidiabetic, Letrozole and Anastrozole anticancer, Venlafaxine antidepressants, and Quetipine and Aripirazole antipsychotic. IndSwift Laboratories Ltd has built a strong presence in 40 plus countries, have a subsidiary in the USA, and set up a state of the art R&D Centre with a USD 5 million investment. Additionally, the production capacity has been increased to 418.18 TPA and its product portfolio continues to expand with compounds like Dutasteride, Cinacalcet, Duloxetine, Mecloxamine citrate, Atomoxetine, Exemestane, and more. In order to explore new opportunities in pharma, the company has entered joint ventures with Wellgen Medicare LLP and Mr. Anshul Jain, and Mr. Ramesh Mehta. As of now, the company has 3 subsidiaries - IndSwift Laboratories Inc in the US, Fortune India Constructions Limited in India, and Halcyon Life Sciences Pvt Ltd in India.

Revenue: ₹8.66Cr as on December 2024 (Q3 FY25)
Net Profit: ₹0.01Cr as on December 2024 (Q3 FY25)
Listing date: 02 Jul, 1997
Chairperson Name: N R Munjal
OrganisationInd-Swift Laboratories Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
CEON R Munjal
E-voting on sharesClick here to vote

FAQs

What is Ind-Swift Laboratories Ltd share price today?

Ind-Swift Laboratories Ltd share price today stands at ₹108.57, Open: ₹107.1, Previous Close: ₹110.26, High: ₹109.84, Low: ₹105.81, 52 Week High: ₹186, 52 Week Low: ₹68.72.

What is today's traded volume of Ind-Swift Laboratories Ltd?

Today's traded volume of Ind-Swift Laboratories Ltd is 3.36L. Which means that 3.36L shares of Ind-Swift Laboratories Ltd were bought and sold on the stock market during today's trading session.

What is Ind-Swift Laboratories Ltd's market cap today?

Today's market capitalisation of Ind-Swift Laboratories Ltd is ₹658.14 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Ind-Swift Laboratories Ltd?

Ind-Swift Laboratories Ltd’s 52 week high is ₹186 and 52 week low is ₹68.72. The current share price of Ind-Swift Laboratories Ltd is ₹108.57, which is -41.63% down from its 52 week high and 57.99% up from its 52 week low.